AJPB
Issue:
March/April 2014
Volume:
6
Number:
2
Drug Trends
Sara C. Erickson, PharmD; Wenyi Qiu, MS; Crystal R. Maas-Patel, PharmD; Sharon M. Wang, PharmD, MS; and Bimal V. Patel, PharmD, MS
This article is an early utilization review of newer, more effective, and more costly regimens for the treatment of hepatitis C.
From the Editor
Jan E. Berger, MD, MJā€”Editor-in-Chief
There are 10 steps that need to be taken to help payers more adequately address the problem of inappropriate prescribing of pain medications.
Letters to the Editor
John Smith, MD, PhD
Original Research
Catherine I. Starner, PharmD, BCPS; R. Scott McClelland, PharmD; Yang Qiu, MS; Richard A. Zabinski, PharmD; Nancy Cotter, PharmD; and Patrick P. Gleason, PharmD, BCPS, FCCP
This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Patient Advocacy
Myrl Weinberg, FASAE, CAE
As the administration looks at improving the insurance marketplace, patient advocates are developing a wish list of modifications to ensure that it is more patient focused.
Review Article
David Calabrese, RPh, MHP; Neil B. Minkoff, MD; and Kristine Rawlings, PharmD
Pharmacosynchrony is the application of innovative clinical, analytic, and technologic pharmacy solutions to drive improved care coordination and higher-quality, more patient-centered care.
Specialty Healthcare Benefits Council
Cynthia R. Hennen, BS, RPh; and James A. Jorgenson, RPh, MS, FASHP
Successful performance of medication reconciliation can have a positive impact on patient response to a hospital stay as well as support improvement in clinical quality and financial outcome.